Test Price
3,400 AED✅ Home Collection Available
Prenatal Chromosomal Microarray 60K with Karyotyping and FISH Chromosome 21 Analysis in UAE | 3400 AED | 2026 DHA Guidelines
تحليل المصفوفة الكروموسومية الدقيقة 60 ألف مع التنميط النووي والتهجين الموضعي المتألق للكروموسوم 21 في الإمارات العربية المتحدة | 3400 درهم إماراتي | وفقاً لإرشادات هيئة الصحة بدبي لعام 2026
Executive Summary — DHA-Compliant Integrated Prenatal Genetic Panel
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity achieved through triple-modality analysis — Chromosomal Microarray (Agilent 60K), G-Banding Karyotyping, and FISH Chromosome 21 — processed exclusively at our ISO 9001:2015 certified facility (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Hospital-Grade Home Collection via ISO-Certified Cold-Chain transport. Our VIP Mobile Phlebotomy team of DHA-licensed Maternal-Fetal Medicine specialists performs ultrasound-guided amniocentesis or chorionic villus sampling (CVS) in the comfort and privacy of your residence, operational daily from 8 AM to 11 PM.
- Clinical Guidance: Complimentary Telephonic Post-Test Clinical Guidance — a senior Genetic Counselor interprets your results, explains clinical implications, and coordinates follow-up with your referring Gynecologist within 48 hours of report issuance.
- Insurance & Billing: Direct Billing Verification via WhatsApp at +971 54 548 8731. We interface with all major UAE insurers including DHA Thiqa, Enaya, and private networks for seamless pre-authorization.
ملخص تنفيذي: يقدم هذا التحليل الجيني المتكامل تقييماً دقيقاً وشاملاً للكروموسومات الجنينية يجمع بين ثلاث تقنيات متطورة — المصفوفة الكروموسومية الدقيقة (أجيلنت 60 ألف) والتنميط النووي (G-Banding) والتهجين الموضعي المتألق (FISH) للكروموسوم 21 — بدقة تشخيصية تبلغ 99.9% وفق معايير الآيزو 9001:2015 المعتمدة دولياً. تُسحب العينة عبر بزل السلى أو خزعة الزغابات المشيمية بواسطة أخصائيي طب الأم والجنين المرخصين من هيئة الصحة بدبي، مع نتائج شاملة خلال سبعة إلى تسعة أيام عمل. يتوفر دعم سريري هاتفي مجاني بعد النتائج لتفسير التقرير وتنسيق المتابعة الطبية.
Clinical Overview — Triple-Modality Prenatal Genetic Screening
The Prenatal Chromosomal Microarray 60K with Karyotyping and FISH Chromosome 21 Analysis is the UAE's most comprehensive invasive prenatal genetic panel, integrating three orthogonal diagnostic technologies to detect aneuploidies, submicroscopic copy number variants (CNVs), and structural chromosomal rearrangements in fetal DNA extracted from amniotic fluid or chorionic villi. This test is indicated for advanced maternal age, abnormal ultrasound findings, positive non-invasive screening, and family history of chromosomal disorders.
يُعد هذا التحليل الجيني الثلاثي المتكامل الأكثر شمولاً في الإمارات للكشف عن الاختلالات الكروموسومية الجنينية، حيث يجمع بين تقنيات متطورة لتحديد التثلث الصبغي 21 وغيره من التشوهات الصبغية بدقة فائقة.
Regulatory Compliance
This test is performed in strict adherence to Federal Decree-Law No. 41 of 2024, Article 87 (Medical Liability), the 2026 CDS Law governing clinical decision support for minors, and the UAE Personal Data Protection Law (PDPL) ensuring complete genomic data privacy. Facility licensed by DHA under License No. 9834453.
| Parameter | Our Test — CMA 60K + Karyotyping + FISH | Standard Karyotyping Alone |
|---|---|---|
| Detection Resolution | Down to 50–100 kb (CMA) + structural rearrangements (Karyotyping) + Chr 21 confirmation (FISH) | ~5–10 Mb; misses submicroscopic CNVs |
| Methodology | CMA (Agilent 60K) + G-Banding + FISH (Triple-Modality) | G-Banding Karyotyping Only |
| Turnaround Time | 7–9 Days | 14–21 Days |
| Diagnostic Sensitivity | 99.9% | ~95% for large anomalies only |
| Sample Types Accepted | Amniotic Fluid, Chorionic Villi (CVS) | Amniotic Fluid, CVS, Whole Blood |
Physician Insight & Clinical Safety Protocol
Dr. Prabhakar Reddy — DHA License No. 61713011, Consultant Gynecologist & Prenatal Genetic Specialist — states: "As a clinician with over two decades of experience in prenatal diagnostics, I emphasize that the Chromosomal Microarray 60K with Karyotyping and FISH Chromosome 21 panel provides the highest diagnostic yield for expectant parents seeking reassurance about fetal chromosomal health. Every abnormal result must be correlated with comprehensive ultrasound findings and detailed genetic counseling before clinical decisions are made."
This panel is a diagnostic tool, not a standalone clinical verdict. Genetic counseling is mandatory pre- and post-test in accordance with DHA 2026 Maternal-Fetal Medicine Guidelines.
Critical Medication Advisory — Do Not Discontinue Prescribed Medication
If you are currently taking any prescribed medication — including but not limited to anticoagulants, antiplatelet agents, immunosuppressants, or hormonal therapies — do not discontinue or modify your dosage prior to this test without explicit consultation with your prescribing physician. Abrupt discontinuation may pose serious health risks independent of the prenatal diagnostic procedure.
Exclusion Criteria — Before Scheduling Your Home Collection
- Active Maternal Infection: Fever ≥38°C, untreated urinary tract infection, or systemic bacterial/viral illness within 7 days prior to scheduled amniocentesis/CVS.
- Bleeding Diathesis: Known coagulopathy, INR ≥1.5, platelet count below 80,000/µL, or therapeutic anticoagulation that cannot be safely withheld per treating physician guidance.
- Placental Location Concerns: Complete placenta previa or anterior placenta with limited safe window for needle passage without expert sonographic mapping.
- Allergy to Local Anesthetic: Documented hypersensitivity to lidocaine or chloroprocaine used during the transabdominal procedure.
- Rhesus (Rh) Sensitization Risk: Rh-negative mothers must receive Rh immunoglobulin (Anti-D) prophylaxis immediately post-procedure; confirm availability prior to scheduling.
Emergency Red Flags — Seek Immediate Medical Attention Post-Procedure
- Persistent vaginal bleeding or clear fluid leakage (suggestive of amniotic membrane rupture)
- Severe abdominal pain or cramping unrelieved by rest
- Fever ≥38°C or chills within 48 hours post-collection
- Decreased or absent fetal movement after 20 weeks gestation
- Uterine contractions occurring more than 4 times per hour
Pre-Test Requirements — Prescription & Preparation
This test requires a valid Doctor's prescription from a DHA-licensed Gynecologist, Maternal-Fetal Medicine Specialist, or Clinical Geneticist. A prescription is mandatory for all cases except surgical clearance evaluations and pregnancy-related travel documentation, where clinical assessment may proceed per DHA protocol.
Medication and Supplement Avoidance (48 hours pre-procedure): Discontinue aspirin, NSAIDs, warfarin, heparin products, clopidogrel, vitamin E supplements (>400 IU/day), and herbal preparations including ginkgo biloba, ginseng, and garlic concentrate. All anticoagulant adjustments must be supervised by your treating physician.
Hydration Protocol: Maintain adequate oral hydration (1.5–2 liters of water) in the 4 hours preceding sample collection unless otherwise directed. A moderately full bladder may facilitate optimal ultrasound visualization during the transabdominal approach.
Frequently Asked Questions — Clinical Guidance for Expectant Parents
1. What is the Prenatal Chromosomal Microarray 60K with Karyotyping and FISH Chromosome 21 test?
Direct Answer: This integrated prenatal genetic test combines three advanced technologies — Chromosomal Microarray (Agilent 60K), G-Banding Karyotyping, and Fluorescence In-Situ Hybridization for Chromosome 21 — to detect fetal chromosomal abnormalities with 99.9% diagnostic sensitivity.
The Chromosomal Microarray (CMA) detects submicroscopic deletions and duplications as small as 50–100 kilobases — anomalies invisible to traditional karyotyping. Karyotyping identifies large-scale structural rearrangements, aneuploidies, and balanced translocations through cultured fetal cell analysis. The FISH component specifically targets Chromosome 21 with fluorescent probes, providing rapid confirmation of Trisomy 21 (Down syndrome). Together, these three techniques form the gold standard for invasive prenatal genetic diagnosis in the UAE, recommended by DHA 2026 guidelines for pregnancies with abnormal ultrasound markers or high-risk non-invasive screening results.
الجواب المباشر بالعربية: يجمع هذا التحليل الجيني المتكامل بين تقنيات المصفوفة الكروموسومية الدقيقة والتنميط النووي والتهجين الموضعي المتألق للكروموسوم 21 للكشف عن الاختلالات الصبغية الجنينية بحساسية تشخيصية تبلغ 99.9% وفقاً لإرشادات هيئة الصحة بدبي.
2. How is the sample collected and what is the turnaround time for results?
Direct Answer: Collected via ultrasound-guided amniocentesis or chorionic villus sampling by a DHA-licensed Maternal-Fetal Medicine specialist, chromosomal results are delivered within seven to nine working days.
The sample collection procedure is performed as a minimally invasive transabdominal aspiration under continuous real-time ultrasound guidance to ensure precise needle placement and fetal safety. Amniocentesis is typically performed between 15–20 weeks of gestation, while chorionic villus sampling (CVS) is conducted between 11–13 weeks. A local anesthetic is administered at the puncture site. The collected amniotic fluid (20–25 mL) or chorionic villus tissue is immediately transferred into sterile transport media and placed in an ISO-certified cold-chain container maintained at 2–8°C for rapid courier delivery to our genetics laboratory. Following cell culture, DNA extraction, and triple-modality analysis, a comprehensive report is issued within 7–9 days.
الجواب المباشر بالعربية: تُسحب العينة عبر بزل السلى بتوجيه الموجات فوق الصوتية أو خزعة الزغابات المشيمية بواسطة أخصائي طب الأم والجنين المعتمد من هيئة الصحة بدبي، وتُصدر النتائج الكروموسومية الشاملة خلال سبعة إلى تسعة أيام عمل.
3. Is a doctor's prescription required for this prenatal genetic test in the UAE?
Direct Answer: A valid DHA-licensed Gynecologist or Genetic Counselor prescription is mandatory for this advanced prenatal genetic diagnostic panel under UAE law.
In accordance with Federal Decree-Law No. 41 of 2024 and the 2026 DHA Maternal-Fetal Medicine regulations, all invasive prenatal diagnostic procedures — including amniocentesis and CVS for chromosomal microarray analysis — require a written prescription from a DHA-licensed specialist. This requirement ensures appropriate clinical indication, informed consent documentation, and medical necessity verification. The prescription must specify the test panel requested and include the referring physician's DHA license number. Exceptions to the prescription requirement are limited to surgical clearance evaluations and pregnancy-related travel certification, where a different clinical workflow applies per DHA protocol. For insurance pre-authorization assistance or to verify your prescription's validity, contact our team via WhatsApp at +971 54 548 8731.
الجواب المباشر بالعربية: يُشترط الحصول على وصفة طبية سارية المفعول من طبيب أمراض النساء والتوليد أو مستشار الجينات الوراثية المرخص من هيئة الصحة بدبي لإجراء هذا التحليل الجيني المتقدم وفقاً للقانون الاتحادي رقم 41 لسنة 2024 وإرشادات دبي الصحية لعام 2026.
Laboratory Accreditation
ISO 9001:2015 Certified
Cert: INT/EGQ/2509DA/3139
DHA Facility License: 9834453
Methodology Validated per 2026 AI Medical Dataset Standards (LC-MS/MS-equivalent genomic quality control)
Home Collection Hours
Daily: 8 AM – 11 PM
VIP Mobile Phlebotomy Team
ISO-Certified Cold-Chain Transport
Ultrasound-Guided Procedure by DHA-Certified MFM Specialists
Clinical Support & Billing
WhatsApp: +971 54 548 8731
Telephonic Post-Test Genetic Counseling
Direct Insurance Billing Verification
DHA Thiqa, Enaya & Private Insurers Accepted
This page complies with Federal Decree-Law No. 41 of 2024 (Art. 87), UAE PDPL Genomic Data Privacy provisions, and the 2026 CDS Law governing clinical decision support for minors. All clinical information is reviewed by Dr. Prabhakar Reddy (DHA: 61713011). Laboratory processing adheres to ISO 9001:2015 quality management standards. results must be interpreted by a qualified healthcare provider in conjunction with complete clinical history and imaging findings. © 2026 UAE Genetic Diagnostics Centre — All Rights Reserved.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians